✦ LIBER ✦

A six-month multicentre, double-blind, bromocriptine-controlled study of the safety and efficacy of ropinirole in the treatment of patients with Parkinson's disease not optimally controlled byl-dopa

✍ Scribed by E. R. Brunt; D. J. Brooks; A. D. Korczyn; J.-L. Montastruc; F. Stocchi; on behalf of the 043 Study Group

Publisher: Springer
Year: 2002
Tongue: English
Weight: 79 KB
Volume: 109
Category: Article
ISSN: 1435-1463
DOI: 10.1007/s007020200040

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A multicentre double-blind placebo-contr

A multicentre double-blind placebo-controlled study investigating the anxiolytic efficacy of hydroxyzine in patients with generalized anxiety

✍ T. Darcis; M. Ferreri; J. Natens; B. Burtin; P. Deram 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 513 KB

The efficacy of hydroxyzine was investigated in 110 patients suffering from generalized anxiety, in a double-blind placebo controlled multicentre study. Oral hydroxyzine 50mg/day for four weeks significantly improved standard measurements of anxiety compared with placebo control. These improvements

A multicentre, randomized, double-blind,

A multicentre, randomized, double-blind, placebo-controlled study to evaluate the efficacy, tolerability and safety of two doses of metrifonate in patients with mild-to-moderate Alzheimer's disease: the MALT study

✍ Bruno Dubois; Ian McKeith; Jean-Marc Orgogozo; Owen Collins; Didier Meulien 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 139 KB 👁 3 views

Background. Metrifonate is a long-lasting acetylcholinesterase inhibitor being developed for the symptomatic treatment of Alzheimer's disease (AD). Objectives. This study compared the ecacy, tolerability and safety of two doses of metrifonate in patients with mild-to-moderate AD, over a 26-week tre

A double-blind comparison of the efficac

A double-blind comparison of the efficacy and safety of ivermectin and diethylcarbamazine in a placebo controlled study of Senegalese patients with onchocerciasis

✍ S. Diallo; M.A. Aziz; M. Lariviere; J.S. Diallo; I. Diop-Mar; O. N'Dir; S. Badia 📂 Article 📅 1986 🏛 Elsevier Science 🌐 English ⚖ 838 KB

Abatacept in the treatment of patients w

Abatacept in the treatment of patients with psoriatic arthritis: Results of a six-month, multicenter, randomized, double-blind, placebo-controlled, phase II trial

✍ Philip Mease; Mark C. Genovese; Geoffrey Gladstein; Alan J. Kivitz; Christopher 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 215 KB 👁 3 views

Efficacy and safety of rebamipide for th

Efficacy and safety of rebamipide for the treatment of dry mouth symptoms in patients with Sjögren’s syndrome: a double-blind placebo-controlled multicenter trial

✍ Susumu Sugai; Hiroki Takahashi; Shuji Ohta; Makoto Nishinarita; Masami Takei; Sh 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 413 KB

Comparison of the clinical efficacy and

Comparison of the clinical efficacy and safety of subcutaneous versus oral administration of methotrexate in patients with active rheumatoid arthritis: Results of a six-month, multicenter, randomized, double-blind, controlled, phase IV trial

✍ J. Braun; P. Kästner; P. Flaxenberg; J. Währisch; P. Hanke; W. Demary; U. von Hi 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 370 KB 👁 3 views